Keywords
DementiaDiseaseMedicineContext (archaeology)Cognitive impairmentAcetylcholinesteraseClinical significanceAmyloid (mycology)PathologyInternal medicineBioinformaticsBiologyBiochemistryEnzyme
Affiliated Institutions
Related Publications
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ <sub>42</sub> in humans
Abstract Objectives Amyloid‐β 42 (Aβ 42 ) appears central to Alzheimer's disease (AD) pathogenesis and is a major component of amyloid plaques. Mean cerebrospinal fluid (CSF) Aβ...
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia. This long “preclinical” phase of AD would provide ...
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Many potential treatments for Alzheimer's disease target amyloid-β peptides (Aβ), which are widely presumed to cause the disease. The microtubule-associated protein tau is also ...
Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice
Alzheimer's disease presents morphologically with senile plaques, primarily made of extracellular amyloid-beta (A beta) deposits, and neurofibrillary lesions, which consist of i...
Publication Info
- Year
- 2003
- Type
- review
- Volume
- 2
- Issue
- 10
- Pages
- 605-613
- Citations
- 1278
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1278
OpenAlex
Cite This
Kaj Blennow,
Harald Hampel
(2003).
CSF markers for incipient Alzheimer's disease.
The Lancet Neurology
, 2
(10)
, 605-613.
https://doi.org/10.1016/s1474-4422(03)00530-1
Identifiers
- DOI
- 10.1016/s1474-4422(03)00530-1